drugset / Trial / NCT02344875

Clinical Pharmacology of FYU-981 (Elder Subjects)

NCT02344875

Phase 1 Completed 24 enrolled Fuji Yakuhin Co., Ltd.
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to assess the pharmacokinetics, safety and pharmacodynamics after single oral administration of FYU-981 to male and female elder subjects in comparison with non-elder subjects.

Timeline

Start
2014-05
Primary completion
2014-06
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dotinurad Small molecule 1 mg Oral

Indications

No indication recorded.